highly significantP = 0.0057
Treatment of female B6D2F1 mice bearing B16 melanoma allografts with 125 mg/kg of eugenol resulted in a small, but highly significant ( P = 0.0057), 2.4-day tumor growth delay.
Treatment of female B6D2F1 mice bearing B16 melanoma allografts with 125 mg/kg of eugenol resulted in a small, but highly significant ( P = 0.0057), 2.4-day tumor growth delay.